Van Morris

Oct 11, 2024 | digitalcommons.library.tmc.edu | Benny Johnson |Van Morris |Xuemei Wang |Arvind Dasari

Although V600E accounts for the majority of the BRAF mutations in metastatic colorectal cancer (mCRC), non-V600 BRAF variants have been shown in recent years to represent a distinct molecular subtype. This study provides a comprehensive profile of BRAF variants in mCRC using a large genomic database of circulating tumor DNA (ctDNA) and analyzing clinical outcomes in a cohort of patients with atypical (non-V600) BRAF variants (aBRAF; class II, class III, unclassified).

Mar 6, 2024 | brnw.ch | Van Morris

Anal cancer can be hard to talk about. And, even when it is talked about, anal cancer is often mistaken for — or lumped together with — colorectal cancer, instead of being recognized as the distinct type of cancer that it is. But talking about anal cancer is important, both for educational purposes and to allow those affected by the disease to feel less alone — especially with rates of HPV-related anal cancer climbing. The topic may be a bit uncomfortable, but it isn’t without hope.

Feb 9, 2024 | mdpi.com | Benny Johnson |Van Morris |Xuemei Wang |Arvind Dasari

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.